Gold(I) phosphine compounds as parasite attenuating agents for malaria vaccine and drug development

被引:0
作者
Ssemaganda, Aloysious [1 ]
Low, Leanne M. [1 ]
Verhoeft, Krista R. [1 ,4 ]
Wambuzi, Mathias [2 ]
Kawoozo, Barbarah [2 ]
Nabasumba, Sharon B. [2 ]
Mpendo, Juliet [2 ]
Bagaya, Bernard S. [2 ,3 ]
Kiwanuka, Noah [2 ,5 ]
Stanisic, Danielle I. [1 ]
Berners-Price, Susan J. [1 ]
Good, Michael F. [1 ]
机构
[1] Griffith Univ, Inst Glyc, Gold Coast Campus, Southport, Qld 4222, Australia
[2] Uganda Virus Res Inst, UVRI IAVI HIV Vaccine Program, POB 49, Entebbe, Uganda
[3] Makerere Univ, Dept Immunol & Mol Biol, Sch Biomed Sci, Coll Hlth Sci, POB 7072, Kampala, Uganda
[4] Univ Hong Kong, Li Ka Shing Fac Med, L-10-56,10-F,Lab Block,21 Sassoon Rd, Pok Fu Lam, Hong Kong, Peoples R China
[5] Makerere Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Coll Hlth Sci, POB 7072, Kampala, Uganda
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
THIOREDOXIN REDUCTASE; ANTITUMOR-ACTIVITY; PLASMODIUM-KNOWLESI; POTENT ANTIMALARIAL; IN-VITRO; GLUTATHIONE; AURANOFIN; COMPLEXES; CHEMISTRY; IMMUNITY;
D O I
10.1039/c7mt00311k
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Here, the anti-malarial activity of two gold(i) phosphine compounds auranofin and [Au(d2pype)(2)]Cl (where d2pype is 1,2-bis(di-2-pyridylphosphino)ethane), were examined to inform their use as potential drugs and malaria parasite-attenuating agents. In vitro, the gold compounds were active against Plasmodium falciparum and P. knowlesi as well as the rodent parasite P. chabaudi AS. Attenuation of the parasite was observed when mice were inoculated with P. chabaudi AS infected red blood cells treated in vitro with [Au(d2pype)(2)]Cl (1 or 2 M) or auranofin (2 M) for 2 or 3 h. Quantitative PCR data showed persistence of low levels of parasite DNA up to 8 days post inoculation. In some experiments, there was microscopically detectable parastiemia following inoculation which subsequently cleared. Following 1 or 3 doses of gold compound-treated parasitized red blood cells (pRBCs), protection was not observed when these mice were subsequently challenged with wild type P. chabaudi AS. In experiments where microscopically detectable parasites were observed following in vivo inoculation, mice were subsequently fully protected against a challenge infection with wildtype parasites. In an infect-and-treat rodent model, the gold compounds were unable to inhibit P. chabaudi AS growth in vivo when administered orally. Gold compounds act via the inhibition of antioxidant systems which are critical in the pathogen's survival from attack by the host oxidants. In vitro, they directly inhibit the parasite thioredoxin reductase, hence the observed suppressive activity. On the other hand, in vivo, the gold compounds may not be readily available for absorption and thus pharmacokinetic studies will be required to further examine drug bioavailability following administration. With structural differences in redox mechanisms of P. falciparum and the human host being identified, gold compounds can be better designed to more efficiently target and selectively inhibit the parasite.
引用
收藏
页码:444 / 454
页数:11
相关论文
共 52 条
[1]   Beneficial effect of aurothiomalate on murine malaria [J].
Alesutan, Ioana ;
Bobbala, Diwakar ;
Qadri, Syed M. ;
Estremera, Adriana ;
Foeller, Michael ;
Lang, Florian .
MALARIA JOURNAL, 2010, 9 :118
[2]   Macromolecular Bases of Antischistosomal Therapy [J].
Angelucci, Francesco ;
Miele, Adriana Erica ;
Boumis, Giovanna ;
Brunori, Maurizio ;
Dimastrogiovanni, Daniela ;
Bellelli, Andrea .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2011, 11 (16) :2012-2028
[3]   Inhibition of Schistosoma mansoni Thioredoxin-glutathione Reductase by Auranofin STRUCTURAL AND KINETIC ASPECTS [J].
Angelucci, Francesco ;
Sayed, Ahmed A. ;
Williams, David L. ;
Boumis, Giovanna ;
Brunori, Maurizio ;
Dimastrogiovanni, Daniela ;
Miele, Adriana E. ;
Pauly, Frida ;
Bellelli, Andrea .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (42) :28977-28985
[4]  
[Anonymous], 2016, World malaria report 2016, P186, DOI DOI 10.4135/9781452276151.N221
[5]   Adaptation of the [3H]Hypoxanthine Uptake Assay for In Vitro-Cultured Plasmodium knowlesi Malaria Parasites [J].
Arnold, Megan S. J. ;
Engel, Jessica A. ;
Chua, Ming Jang ;
Fisher, Gillian M. ;
Skinner-Adams, Tina S. ;
Andrews, Katherine T. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (07) :4361-4363
[6]   Thioredoxin reductase as a pathophysiological factor and drug target [J].
Becker, K ;
Gromer, S ;
Schirmer, RH ;
Müller, S .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (20) :6118-6125
[7]   Oxidative stress in malaria parasite-infected erythrocytes: host-parasite interactions [J].
Becker, K ;
Tilley, L ;
Vennerstrom, JL ;
Roberts, D ;
Rogerson, S ;
Ginsburg, H .
INTERNATIONAL JOURNAL FOR PARASITOLOGY, 2004, 34 (02) :163-189
[8]  
Berners-Price S.J., 1988, STRUCT BONDING, V70, P27, DOI [10.1007/3-540-50130-42, DOI 10.1007/3-540-50130-42]
[9]  
Berners-Price S.J., 2011, Bioinorganic Medicinal Chemistry, P197, DOI DOI 10.1002/9783527633104.CH7
[10]   NMR and structural studies of gold(I) chloride adducts with bidentate 2-, 3- and 4-pyridyl phosphines [J].
Berners-Price, SJ ;
Bowen, RJ ;
Hambley, TW ;
Healy, PC .
JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS, 1999, (08) :1337-1346